Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-001221-98Phase 2Completed
Phase 2, randomised, triple-blind trial of dexamethasone and ropivacaine (3 arms), sponsored by Medical University of Vienna. Primary endpoints: Duration of sensory nerve blockade, Sensory onset time and 2 more. Started May 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-001221-98.